Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Amygdala Neurosciences initiates phase Ib study of ALDH2 inhibitor

Aug. 2, 2017

Emergent BioSolutions' development of auto-injector for nerve agent antidote gets financial support

Aug. 1, 2017

FDA grants priority review to RBP-6000 NDA, clearance for buprenorphine assay

Aug. 1, 2017

Pfizer discloses dopamine D3 receptor ligands

July 28, 2017

Opiant reports phase I data on OPNT-002

July 21, 2017

Rolling NDA submission completed for CAM-2038 to treat opioid use disorder

July 20, 2017

MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine

July 14, 2017

FDA grants orphan drug designation to ResQ's LipidRescue

June 16, 2017

Fennec launches European Named Patient Program for sodium thiosulfate

May 31, 2017

Selecta initiates phase I trial of nicotine vaccine candidate SELA-070

May 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...